FMRP Mediates mGluR5-Dependent Translation of Amyloid Precursor Protein

Cited by (289)

Items 101–200 of 289

1. Impact of acamprosate on plasma amyloid-β precursor protein in youth: A pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker
   Craig A. Erickson, Balmiki Ray, Bryan Maloney, Logan K. Wink, Katherine A. Bowers, Tori L. Schaefer, Christopher J. McDougle, Deborah K. Sokol, Debomoy K. Lahiri · 2014 · Journal of Psychiatric Research
2. A lentiviral sponge for miR-101 regulates RanBP9 expression and amyloid precursor protein metabolism in hippocampal neurons
   Christian Barbato, Silvia Pezzola, Cinzia Caggiano, Martina Antonelli, Paola Frisone, Maria Teresa Ciotti, Francesca Ruberti · 2014 · Frontiers in Cellular Neuroscience
3. From FMRP Function to Potential Therapies for Fragile X Syndrome
   Ferzin Sethna, Changjong Moon, Hongbing Wang · 2013 · Neurochemical Research
4. Metabotropic Glutamate Receptors in Central Nervous System Diseases
   Anna V. Golubeva, Rachel D. Moloney, Richard M. O’Connor, Timothy G. Dinan, John F. Cryan · 2016 · Current Drug Targets
5. Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism
   Cara J. Westmark, Deborah K. Sokol, Bryan Maloney, Debomoy K. Lahiri · 2016 · Molecular Psychiatry
6. Dendritic protein synthesis in the normal and diseased brain
   S. Swanger, G. Bassell · 2012 · Neuroscience
7. Regulation of the α-secretase ADAM10 at transcriptional, translational and post-translational levels
   Bruno Vincent · 2016 · Brain Research Bulletin
8. Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis
   Olfa Khalfallah, Marielle Jarjat, Laëtitia Davidovic, Nicolas Nottet, Sandrine Cestèle, Massimo Mantegazza, Barbara Bardoni · 2016 · Stem Cells
9. Defects in translational regulation contributing to human cognitive and behavioral disease
   Darnell, JC · 2011 · Current Opinion in Genetics & Development
10. Opposite Dysregulation of Fragile-X Mental Retardation Protein and Heteronuclear Ribonucleoprotein C Protein Associates with Enhanced APP Translation in Alzheimer Disease
    Antonella Borreca, Katia Gironi, Giuseppina Amadoro, Martine Ammassari‐Teule · 2015 · Molecular Neurobiology
11. Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque
    Jason P. Holland, Steven H. Liang, Benjamin H. Rotstein, Thomas Lee Collier, Nickeisha A. Stephenson, Ivan D. Greguric, Neil Vasdev · 2013 · Journal of Labelled Compounds and Radiopharmaceuticals
12. Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue
    Balmiki Ray, Deborah K. Sokol, Bryan Maloney, Debomoy K. Lahiri · 2016 · Scientific Reports
13. Soy-Based Diet Exacerbates Seizures in Mouse Models of Neurological Disease
    Cara J. Westmark, Pamela R. Westmark, James S. Malter · 2013 · Journal of Alzheimer s Disease
14. Coordination between Translation and Degradation Regulates Inducibility of mGluR-LTD
    Matthew E Klein, Pablo E. Castillo, Bryen A. Jordan · 2015 · Cell Reports
15. Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents
    Junya Lv, Lijuan Xing, Xin Zhong, Kai Li, Mingyan Liu, Ke Du · 2023 · Biomedicine & Pharmacotherapy
16. Novel Contribution of Secreted Amyloid-β Precursor Protein to White Matter Brain Enlargement in Autism Spectrum Disorder
    Deborah K. Sokol, Bryan Maloney, Cara J. Westmark, Debomoy K. Lahiri · 2019 · Frontiers in Psychiatry
17. FMRP S499 Is Phosphorylated Independent of mTORC1-S6K1 Activity
    Christopher M. Bartley, Rachel A. O’Keefe, Angélique Bordey · 2014 · PLoS ONE
18. G‐quadruplex regulation of neural gene expression
    John W. Cave, Dianna E. Willis · 2021 · FEBS Journal
19. The Fragile X Mental Retardation Protein in Circadian Rhythmicity and Memory Consolidation
    Cheryl L. Gatto, Kendal S. Broadie · 2009 · Molecular Neurobiology
20. EEG abnormalities and seizures in genetically diagnosed Fragile X syndrome
    Takijah T. Heard, Sriram Ramgopal, Jonathan D. Picker, Sharyn A. Lincoln, Alexander Rotenberg, Sanjeev V. Kothare · 2014 · International Journal of Developmental Neuroscience
21. Preparation of Synaptoneurosomes from Mouse Cortex using a Discontinuous Percoll-Sucrose Density Gradient
    Pamela R. Westmark, Cara J. Westmark, Athavi Jeevananthan, James S. Malter · 2011 · Journal of Visualized Experiments
22. A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
    Clare L. Garcin, Shukry James Habib · 2017 · Results and problems in cell differentiation
23. Aβ/Amyloid Precursor Protein-Induced Hyperexcitability and Dysregulation of Homeostatic Synaptic Plasticity in Neuron Models of Alzheimer’s Disease
    Isak Martinsson, Luís Quintino, Megg G. Garcia, Sabine C Konings, Laura Torres-Garcia, Alexander Svanbergsson, Oliver Stange, Rebecca England, Tomas Deierborg, Jiayi Li et al. · 2022 · Frontiers in Aging Neuroscience
24. Coding region
    Eun Kyung Lee, Myriam Gorospe · 2011 · RNA Biology
25. Sh3rf2/POSHER Protein Promotes Cell Survival by Ring-mediated Proteasomal Degradation of the c-Jun N-terminal Kinase Scaffold POSH (Plenty of SH3s) Protein
    Michael Wilhelm, Nickolay V. Kukekov, Travis L. Schmit · 2011 · Journal of Biological Chemistry
26. Fragile X Syndrome and Alzheimers Disease: Another Story About APP and β -Amyloid
    James S. Malter, Brian C. Ray, Pamela R. Westmark, Cara J. Westmark · 2010 · Current Alzheimer Research
27. Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [11C]ABP688 PET imaging and ex vivo immunoblotting
    Xiaotian T. Fang, Jonas Eriksson, Gunnar Antoni, Ulrika Yngve, Linda Cato, Lars Lannfelt, Dag Sehlin, Stina Syvänen · 2016 · Neuropharmacology
28. Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice
    Diana W. Shineman, Bin Zhang, Susan N. Leight, Domenico Praticò, Virginia M.‐Y. Lee · 2008 · Journal of Neuroscience
29. Metabotropic Glutamate Receptor 5 in Down's Syndrome Hippocampus During Development: Increased Expression in Astrocytes
    Anand M. Iyer, Jackelien van Scheppingen, Ivan Milenković, Jasper J. Anink, Dmitry Lim, Armando A. Genazzani, Homa Adle‐Biassette, Gábor Géza Kovács, Eleonora Aronica · 2014 · Current Alzheimer Research
30. Fragile X syndrome neurobiology translates into rational therapy
    Sien Braat, R. Frank Kooy · 2014 · Drug Discovery Today
31. Quantitative Phosphoproteomics of MurineFmr1-KO Cell Lines Provides New Insights into FMRP-Dependent Signal Transduction Mechanisms
    Katarina Matić, Timo Eninger, Barbara Bardoni, Laëtitia Davidovic, Boris Maček · 2014 · Journal of Proteome Research
32. Fragile X and APP: a Decade in Review, a Vision for the Future
    Cara J. Westmark · 2018 · Molecular Neurobiology
33. G-quadruplexes and associated proteins in aging and Alzheimer’s disease
    M. J. Vijay Kumar, Rodrigo Morales, Andrey S. Tsvetkov · 2023 · Frontiers in Aging
34. Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders
    Timothy D. Folsom, PAUL D. THURAS, S. Hossein Fatemi · 2015 · Schizophrenia Research
35. General RBP expression in human tissues as a function of age
    Masuda, Kiyoshi, Kuwano, Yuki, Nishida, Kensei, Rokutan, Kazuhito · 2012 · Ageing Research Reviews
36. APP depletion alters selective pre- and post-synaptic proteins
    Martinsson, Isak, Capetillo-Zarate, Estibaliz, Faideau, Mathilde, Willén, Katarina, Esteras, Noemi, Frykman, Susanne, Tjernberg, Lars O., Gouras, Gunnar K. · 2019 · Molecular and Cellular Neuroscience
37. MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta.
    Cara J. Westmark, Pamela R. Westmark, James S. Malter · 2009 · PubMed Central
38. ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI
    Jin-Chen Yang, Lillian Chi, Sara Teichholtz, Andrea Schneider, Rawi Nanakul, Ralph Nowacki, Andreea L. Seritan, Bruce Reed, Charles S DeCarli, Vicente J. Iragui et al. · 2014 · Neuropsychologia
39. Interactions of amyloid coaggregates with biomolecules and its relevance to neurodegeneration
    Kazuma Murakami, Kenjiro Ono · 2022 · The FASEB Journal
40. Conceptualizing neurodevelopmental disorders through a mechanistic understanding of fragile X syndrome and Williams syndrome
    Lawrence K. Fung, Eve‐Marie Quintin, Brian W. Haas, Allan L. Reiss · 2012 · Current Opinion in Neurology
41. FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game
    Louis Bleuzé, Viviana Triaca, Antonella Borreca · 2021 · Frontiers in Molecular Biosciences
42. RNA and neuronal function: the importance of post-transcriptional regulation
    Vandita D Bhat, Jagannath Jayaraj, Kavita Babu · 2022 · Oxford Open Neuroscience
43. Myosin Va associates with mRNA in ribonucleoprotein particles present in myelinated peripheral axons and in the central nervous system
    Aldo J. Calliari, Joaquina Farías, Agostina Puppo · 2013 · Developmental Neurobiology
44. Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging
    Kanchan Singh, S. Prasad · 2007 · Molecular Biology Reports
45. Non-coding RNA transcripts: Sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease
    Georges St. Laurent, Mohammad Ali Faghihi, Claes Wahlestedt · 2009 · Neuroscience Letters
46. Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes
    Hansen Wang, Sandipan Bankim Behari Pati, Lucas D. Pozzo‐Miller, Laurie C. Doering · 2015 · Frontiers in Cellular Neuroscience
47. Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington’s disease
    Fabiola Mara Ribeiro, Alison Hamilton, Juliana G. Doria, Isabella M Guimaraes, Sean P. Cregan, Stephen S. G. Ferguson · 2014 · Expert Opinion on Therapeutic Targets
48. APP Causes Hyperexcitability in Fragile X Mice
    Cara J. Westmark, Shih-Chieh Chuang, Seth A. Hays, Mikolaj J. Filon, Brian C. Ray, Pamela R. Westmark, Jay R. Gibson, Kimberly M. Huber, Robert K. S. Wong · 2016 · Frontiers in Molecular Neuroscience
49. Glutamate Receptors in Epilepsy
    Riccardo Bianchi, Robert K. S. Wong, Lisa R. Merlin · 2012 · Oxford University Press eBooks
50. Transcriptional and Post-Transcriptional Regulations of Amyloid-β Precursor Protein (APP) mRNA
    Kaoru Sato, Ken‐ichi Takayama, Makoto Hashimoto, Satoshi Inoue · 2021 · Frontiers in Aging
51. Fragile X syndrome: An aging perspective
    Andrea Schneider, Andrew Ligsay, Randi Jenssen Hagerman · 2013 · Developmental Disabilities Research Reviews
52. Fragile X mental retardation protein expression in Alzheimer’s disease
    Abigail J. Renoux, Nicholas M. Carducci, Arya A. Ahmady, Peter K. Todd · 2014 · Frontiers in Genetics
53. Fragile X mental retardation protein: from autism to neurodegenerative disease
    Hansen Wang · 2015 · Frontiers in Cellular Neuroscience
54. Sleep and diurnal rest-activity rhythm disturbances in a mouse model of Alzheimer’s disease
    Mikolaj J. Filon, Eli P. Wallace, Samantha Wright, Dylan J. Douglas, Lauren I. Steinberg, Carissa L. Verkuilen, Pamela R. Westmark, Rama K. Maganti, Cara J. Westmark · 2020 · SLEEP
55. Pin1 and Alzheimer's disease
    James S. Malter · 2022 · Translational research
56. T-Type Calcium Channels Are Required to Maintain Viability of Neural Progenitor Cells
    Ji‐Woon Kim, Hyun Ah Oh, Sung Hoon Lee et al. · 2018 · Biomolecules & Therapeutics
57. FMRP Regulates the Nuclear Export of Adam9 and Psen1 mRNAs: Secondary Analysis of an N6-Methyladenosine Dataset
    Cara J. Westmark, Bryan Maloney, Reid S. Alisch · 2020 · Scientific Reports
58. An “Omic” Overview of Fragile X Syndrome
    Olivier Dionne, François Corbin · 2021 · Biology
59. The regulation of AβPP expression by RNA-binding proteins
    Cara J. Westmark, James S. Malter · 2012 · Ageing Research Reviews
60. Local mRNA translation and cytoskeletal reorganization: Mechanisms that tune neuronal responses
    Nikoletta Triantopoulou, Marina Vidaki · 2022 · Frontiers in Molecular Neuroscience
61. Negative Regulation of AβPP Gene Expression by Pur-alpha
    Nune Darbinian, Jianqi Cui, Anna Maria Basile, Luis Del Valle, Jessica Otte, Judith Miklossy A, Bassel E. Sawaya, Shohreh Amini, Kamel Khalili, Jennifer Gordon · 2008 · Journal of Alzheimer s Disease
62. Increasing our understanding of human cognition through the study of fragile X syndrome
    Denise Cook, Erin Nuro, Keith Kazuo Murai · 2013 · Developmental Neurobiology
63. Fragile X mental retardation protein recognizes a G quadruplex structure within the survival motor neuron domain containing 1 mRNA 5′-UTR
    Damian S. McAninch, Ashley M. Heinaman, Cara N. Lang, Kathryn R. Moss, Gary Jonathan Bassell, Mihaela‐Rita Mihailescu, Timothy L. Evans · 2017 · Molecular BioSystems
64. High apolipoprotein E4 allele frequency in FXTAS patients
    Francisca Silva, Laia Rodríguez‐Revenga, Irene Madrigal, María Isabel Álvarez‐Mora, Rafael Oliva, Montserrat Milà · 2013 · Genetics in Medicine
65. Rescue of Fmr1 phenotypes with mGluR5 inhibitors: MRZ-8456 versus AFQ-056
    Pamela R. Westmark, Andrzej Dekundy, Andreas Gravius, Wojciech Danysz, Cara J. Westmark · 2018 · Neurobiology of Disease
66. Fragile X Mental Retardation Protein expression in the retina is regulated by light
    E.M. Guimarães‐Souza, Olivier Perche, Catherine W. Morgans, Robert M. Duvoisin, Karin da Costa Calaza · 2015 · Experimental Eye Research
67. Protein Binding to Cis-Motifs in mRNAs Coding Sequence Is Common and Regulates Transcript Stability and the Rate of Translation
    Ewa Anna Grzybowska, Maciej Wakuła · 2021 · Cells
68. Exploring cross-tissue DNA methylation patterns: blood–brain CpGs as potential neurodegenerative disease biomarkers
    Vanessa Mendonça, Sheila Coelho Soares‐Lima, Miguel Ângelo Martins Moreira · 2024 · Communications Biology
69. Differential Regulation of N-Myc and c-Myc Synthesis, Degradation, and Transcriptional Activity by the Ras/Mitogen-activated Protein Kinase Pathway
    Katannya Kapeli, Peter J. Hurlin · 2011 · Journal of Biological Chemistry
70. Human Cerebral Cortex Proteome of Fragile X-Associated Tremor/Ataxia Syndrome
    Katharine Nichole Holm, Anthony W. Herren, Sandra L. Taylor, Jamie Leah Randol, Kyoungmi Kim, Glenda M. Espinal, Verónica Martínez‐Cerdeño, Isaac N. Pessah, Randi Jenssen Hagerman, Paul J. Hagerman · 2021 · Frontiers in Molecular Biosciences
71. Soluble Amyloid Precursor Protein α: Friend or Foe?
    Nicola J. Corbett, Nigel M. Hooper · 2018 · Advances in experimental medicine and biology
72. Age- and sex-related analysis of methylation of 5′-upstream sequences of Fmr-1 gene in mouse brain and modulation by sex steroid hormones
    Kanchan Singh, S. Prasad · 2008 · Biogerontology
73. Meeting at the crossroads: common mechanisms in Fragile X and Down syndrome
    Karen T. Chang, Hyunah Ro, Wei Wang, Kyung‐Tai Min · 2013 · Trends in Neurosciences
74. Modeling Fragile X syndrome in neurogenesis: An unexpected phenotype and a novel tool for future therapies
    Barbara Bardoni, Maria Capovilla, Enzo Lalli · 2017 · Neurogenesis
75. Autism genes and the leukocyte transcriptome in autistic toddlers relate to pathogen interactomes, infection and the immune system. A role for excess neurotrophic sAPPα and reduced antimicrobial Aβ
    Christopher Carter · 2019 · Neurochemistry International
76. mGluR5 Tunes NGF/TrkA Signaling to Orient Spiny Stellate Neuron Dendrites Toward Thalamocortical Axons During Whisker-Barrel Map Formation
    Jui-Yen Huang, Hui‐Chen Lu · 2017 · Cerebral Cortex
77. Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer’s brain molecular pathology
    Ben Readhead, Jean‐Vianney Haure‐Mirande, Bin Zhang, Vahram H. Haroutunian, Sam Gandy, E E Schadt, Joel T. Dudley, M E Ehrlich · 2015 · Molecular Psychiatry
78. Fragile X mental retardation protein coordinates neuron-to-glia communication for clearance of developmentally transient brain neurons
    Chunzhu Song, Kendal S. Broadie · 2023 · Proceedings of the National Academy of Sciences
79. Fragile X Syndrome FMRP Co-localizes with Regulatory Targets PSD-95, GABA Receptors, CaMKIIα, and mGluR5 at Fiber Cell Membranes in the Eye Lens
    Peter H. Frederikse, Anoop Nandanoor, Chinnaswamy Kasinathan · 2015 · Neurochemical Research
80. Glutamate Receptors in Epilepsy: Group I mGluR-Mediated Epileptogenesis
    Riccardo Bianchi, Robert K. S. Wong, Lisa R. Merlin · 2012 · Europe PMC (PubMed Central)
81. Taking STEPs Forward to Understand Fragile X Syndrome
    Susan M. Goebel-Goody, Paul J. Lombroso · 2011 · Results and problems in cell differentiation
82. Post-transcriptional regulation of amyloid precursor protein by microRNAs and RNA binding proteins
    Francesca Ruberti, Christian Barbato, Carlo Cogoni · 2010 · Communicative & Integrative Biology
83. Phenotypic changes in calbindin D28K immunoreactivity in the hippocampus of Fmr1 knockout mice
    M. Real, M. Simón, R. Heredia, Y. D. de Diego, S. Guirado · 2011 · The Journal of comparative neurology
84. Coding relationship links RNA G-quadruplexes and protein RGG motifs in RNA-binding protein autoregulation
    Marlene Adlhart, Daniel E. Hoffmann, Anton A. Polyansky · 2025 · Proceedings of the National Academy of Sciences
85. Translating molecular advances in Down syndrome and Fragile X syndrome into therapies.
    V. Faundez, I. De Toma, B. Bardoni, R. Bartesaghi, D. Nižetić, R. de la Torre, Roi Cohen Kadosh, Yann Hérault, M. Dierssen, M. Potier et al. · 2017 · European Neuropsychopharmacology
86. Systematic Analysis of Protein–Protein and Gene–Environment Interactions to Decipher the Cognitive Mechanisms of Autism Spectrum Disorder
    Masoumeh Farahani, Mostafa Rezaei–Tavirani, Alireza Zali, Mona Zamanian Azodi · 2020 · Cellular and Molecular Neurobiology
87. mTOR : at the crossroads of aging, chaperones, and A lzheimer's disease
    Gunnar K. Gouras · 2012 · Journal of Neurochemistry
88. Effects of Soy-Based Infant Formula on Weight Gain and Neurodevelopment in an Autism Mouse Model
    Cara J. Westmark, Mikolaj J. Filon, Patricia Maina, Lauren I. Steinberg, Chrysanthy Ikonomidou, Pamela R. Westmark · 2022 · Cells
89. Analysis of Nucleotide Variations in Human G-Quadruplex Forming Regions Associated with Disease States
    Aryan Neupane, Julia H. Chariker, Eric Christian Rouchka · 2023 · Genes
90. FRAGILE X SYNDROME AND PREMUTATION‐ASSOCIATED DISORDERS
    Randi Jenssen Hagerman · 2020 · Wiley eBooks
91. Neurodevelopmental disorders and microcephaly: how apoptosis, the cell cycle, tau and amyloid-β precursor protein APPly
    Deborah K. Sokol, Debomoy K. Lahiri · 2023 · Frontiers in Molecular Neuroscience
92. Ketogenic Diet Affects Sleep Architecture in C57BL/6J Wild Type and Fragile X Mice
    Pamela R. Westmark, Aaron K. Gholston, Timothy J. Swietlik, Rama K. Maganti, Cara J. Westmark · 2023 · International Journal of Molecular Sciences
93. The quest for fragile X biomarkers
    Cara J. Westmark · 2014 · Molecular and Cellular Pediatrics
94. Interaction of USF1/USF2 and α-Pal/Nrf1 to Fmr-1 promoter increases in mouse brain during aging
    S. Prasad, Kanchan Singh · 2008 · Biochemical and Biophysical Research Communications
95. Role of fragile X messenger ribonucleoprotein 1 in the pathophysiology of brain disorders: a glia perspective
    Simona D’Antoni, Michela Spatuzza, Carmela Maria Bonaccorso, Maria Vincenza Catania · 2024 · Neuroscience & Biobehavioral Reviews
96. The mGluR Theory of Fragile X: From Mice to Men
    Laura J. Stoppel, Emily K. Osterweil, Mark F. Bear · 2017 · Elsevier eBooks
97. Epigenetically Upregulated T-Type Calcium Channels Contribute to Abnormal Proliferation of Embryonic Neural Progenitor Cells Exposed to Valproic Acid
    Ji‐Woon Kim, Hyun Ah Oh, Sung Rae Kim, Mee Jung Ko, Hana Seung, Sung Hoon Lee, Chan Young Shin · 2020 · Biomolecules & Therapeutics
98. Fragile X family members have important and non-overlapping functions
    Claudia Winograd, Stephanie Ceman · 2011 · BioMolecular Concepts
99. Brain insulin resistance in Down syndrome: Involvement of PI3K-Akt/mTOR axis in early-onset of Alzheimer's disease and its potential as a therapeutic target
    Mansour Azimzadeh, Pike-See Cheah, King‐Hwa Ling · 2024 · Biochemical and Biophysical Research Communications
100. Neurobehavioral features and targeted treatments in fragile X syndrome: Current insights and future directions
     Dejan B. Budimirovic, Phan Q. Duy · 2015 · Engrami